Loading…
Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats
Rituximab was successively labeled with [Ga]-gallium chloride after residulation with freshly prepared cyclic DTPA-dianhydride. The best results of the conjugation were obtained by the addition of 1 ml of a rituximab pharmaceutical solution (5 mg/ml, in phosphate buffer, pH 8) to a glass tube pre-co...
Saved in:
Published in: | Journal of radioanalytical and nuclear chemistry 2007-10, Vol.274 (1), p.175-179 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3 |
---|---|
cites | cdi_FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3 |
container_end_page | 179 |
container_issue | 1 |
container_start_page | 175 |
container_title | Journal of radioanalytical and nuclear chemistry |
container_volume | 274 |
creator | Jalilian, A. R. Mirsadeghi, L. Haji-Hosseini, R. |
description | Rituximab was successively labeled with [Ga]-gallium chloride after residulation with freshly prepared cyclic DTPA-dianhydride. The best results of the conjugation were obtained by the addition of 1 ml of a rituximab pharmaceutical solution (5 mg/ml, in phosphate buffer, pH 8) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25 deg C with continuous mild stirring for 30 minutes. Radio thin-layer chromatography showed an overall radiochemical purity of 96-99% at optimized conditions (specific activity = 300-500 MBq/mg, labeling efficiency 77%). The final isotonic Ga-DTPA-rituximab complex was checked by gel electrophoresis for radiolysis control. Radio-TLC was performed to ensure the formation of only one species, followed by filtration through a 0.22 mum filter. Preliminary in vivo studies in normal rat model was performed to determine the biodistribution of the radioimmunoconjugate up to 6 hours. |
doi_str_mv | 10.1007/s10967-006-6906-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_30122641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30122641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3</originalsourceid><addsrcrecordid>eNotkE9LAzEUxIMoWKsfwNuevEVfks2fPZaqW6FgD_UkEt6mWYhsNzXZBf32bq2XNzDMDI8fIbcM7hmAfsgMKqUpgKKqmg6ckRmTxlCuDZyTGXChqNSCXZKrnD8BoDJGzEi9Sf6ACYcQ-wL7XdGEuAt5SKEZ_7zYFu9K1_hBH7ebBU1hGL_DHpsi9EUf0x67Ymrna3LRYpf9zb_Oydvz03a5ouvX-mW5WFPHtRqoE14aLVVpOEPOy0aAV4iuEppzr2TbKFQG3dFqmTGqbcqdcJWUHh1zKObk7rR7SPFr9Hmw-5Cd7zrsfRyzFcA4VyWbguwUdCnmnHxrD2n6O_1YBvaIzJ6Q2QmZPSKzIH4BL9xe3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>30122641</pqid></control><display><type>article</type><title>Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats</title><source>Springer Link</source><creator>Jalilian, A. R. ; Mirsadeghi, L. ; Haji-Hosseini, R.</creator><creatorcontrib>Jalilian, A. R. ; Mirsadeghi, L. ; Haji-Hosseini, R.</creatorcontrib><description>Rituximab was successively labeled with [Ga]-gallium chloride after residulation with freshly prepared cyclic DTPA-dianhydride. The best results of the conjugation were obtained by the addition of 1 ml of a rituximab pharmaceutical solution (5 mg/ml, in phosphate buffer, pH 8) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25 deg C with continuous mild stirring for 30 minutes. Radio thin-layer chromatography showed an overall radiochemical purity of 96-99% at optimized conditions (specific activity = 300-500 MBq/mg, labeling efficiency 77%). The final isotonic Ga-DTPA-rituximab complex was checked by gel electrophoresis for radiolysis control. Radio-TLC was performed to ensure the formation of only one species, followed by filtration through a 0.22 mum filter. Preliminary in vivo studies in normal rat model was performed to determine the biodistribution of the radioimmunoconjugate up to 6 hours.</description><identifier>ISSN: 0236-5731</identifier><identifier>EISSN: 1588-2780</identifier><identifier>DOI: 10.1007/s10967-006-6906-0</identifier><language>eng</language><ispartof>Journal of radioanalytical and nuclear chemistry, 2007-10, Vol.274 (1), p.175-179</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3</citedby><cites>FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Jalilian, A. R.</creatorcontrib><creatorcontrib>Mirsadeghi, L.</creatorcontrib><creatorcontrib>Haji-Hosseini, R.</creatorcontrib><title>Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats</title><title>Journal of radioanalytical and nuclear chemistry</title><description>Rituximab was successively labeled with [Ga]-gallium chloride after residulation with freshly prepared cyclic DTPA-dianhydride. The best results of the conjugation were obtained by the addition of 1 ml of a rituximab pharmaceutical solution (5 mg/ml, in phosphate buffer, pH 8) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25 deg C with continuous mild stirring for 30 minutes. Radio thin-layer chromatography showed an overall radiochemical purity of 96-99% at optimized conditions (specific activity = 300-500 MBq/mg, labeling efficiency 77%). The final isotonic Ga-DTPA-rituximab complex was checked by gel electrophoresis for radiolysis control. Radio-TLC was performed to ensure the formation of only one species, followed by filtration through a 0.22 mum filter. Preliminary in vivo studies in normal rat model was performed to determine the biodistribution of the radioimmunoconjugate up to 6 hours.</description><issn>0236-5731</issn><issn>1588-2780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNotkE9LAzEUxIMoWKsfwNuevEVfks2fPZaqW6FgD_UkEt6mWYhsNzXZBf32bq2XNzDMDI8fIbcM7hmAfsgMKqUpgKKqmg6ckRmTxlCuDZyTGXChqNSCXZKrnD8BoDJGzEi9Sf6ACYcQ-wL7XdGEuAt5SKEZ_7zYFu9K1_hBH7ebBU1hGL_DHpsi9EUf0x67Ymrna3LRYpf9zb_Oydvz03a5ouvX-mW5WFPHtRqoE14aLVVpOEPOy0aAV4iuEppzr2TbKFQG3dFqmTGqbcqdcJWUHh1zKObk7rR7SPFr9Hmw-5Cd7zrsfRyzFcA4VyWbguwUdCnmnHxrD2n6O_1YBvaIzJ6Q2QmZPSKzIH4BL9xe3g</recordid><startdate>200710</startdate><enddate>200710</enddate><creator>Jalilian, A. R.</creator><creator>Mirsadeghi, L.</creator><creator>Haji-Hosseini, R.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope></search><sort><creationdate>200710</creationdate><title>Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats</title><author>Jalilian, A. R. ; Mirsadeghi, L. ; Haji-Hosseini, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jalilian, A. R.</creatorcontrib><creatorcontrib>Mirsadeghi, L.</creatorcontrib><creatorcontrib>Haji-Hosseini, R.</creatorcontrib><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jalilian, A. R.</au><au>Mirsadeghi, L.</au><au>Haji-Hosseini, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats</atitle><jtitle>Journal of radioanalytical and nuclear chemistry</jtitle><date>2007-10</date><risdate>2007</risdate><volume>274</volume><issue>1</issue><spage>175</spage><epage>179</epage><pages>175-179</pages><issn>0236-5731</issn><eissn>1588-2780</eissn><abstract>Rituximab was successively labeled with [Ga]-gallium chloride after residulation with freshly prepared cyclic DTPA-dianhydride. The best results of the conjugation were obtained by the addition of 1 ml of a rituximab pharmaceutical solution (5 mg/ml, in phosphate buffer, pH 8) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25 deg C with continuous mild stirring for 30 minutes. Radio thin-layer chromatography showed an overall radiochemical purity of 96-99% at optimized conditions (specific activity = 300-500 MBq/mg, labeling efficiency 77%). The final isotonic Ga-DTPA-rituximab complex was checked by gel electrophoresis for radiolysis control. Radio-TLC was performed to ensure the formation of only one species, followed by filtration through a 0.22 mum filter. Preliminary in vivo studies in normal rat model was performed to determine the biodistribution of the radioimmunoconjugate up to 6 hours.</abstract><doi>10.1007/s10967-006-6906-0</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0236-5731 |
ispartof | Journal of radioanalytical and nuclear chemistry, 2007-10, Vol.274 (1), p.175-179 |
issn | 0236-5731 1588-2780 |
language | eng |
recordid | cdi_proquest_miscellaneous_30122641 |
source | Springer Link |
title | Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A55%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preparation%20and%20biodistribution%20of%20%5B67Ga%5D-DTPA-rituximab%20in%20normal%20rats&rft.jtitle=Journal%20of%20radioanalytical%20and%20nuclear%20chemistry&rft.au=Jalilian,%20A.%20R.&rft.date=2007-10&rft.volume=274&rft.issue=1&rft.spage=175&rft.epage=179&rft.pages=175-179&rft.issn=0236-5731&rft.eissn=1588-2780&rft_id=info:doi/10.1007/s10967-006-6906-0&rft_dat=%3Cproquest_cross%3E30122641%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c276t-c3e587564821a224b30e6aac93722e65fb6a68acaac9f1886fb4d3c955eac1ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=30122641&rft_id=info:pmid/&rfr_iscdi=true |